Search research articles
Contact Us
Filters
Showing results (11-20 of 192) with videos related to
Page
of 20
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 22, 2005
Measuring health-related utility: why the disparity between EQ-5D and SF-6D?
Stirling Bryan, Louise Longworth
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Discrete choice experiments in health economics. For better or for worse?
Stirling Bryan, Paul Dolan
International Journal of Health Policy and Management
|
March 12, 2018
Health Services Research Spending and Healthcare System Impact Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal"
Morris L Barer, Stirling Bryan
British Journal of Sports Medicine
|
March 26, 2015
Patient Reported Outcome Measures (PROMs) have arrived in sports and exercise medicine: Why do they matter?
Jennifer C Davis, Stirling Bryan
Social Science & Medicine (1982)
|
August 19, 2007
Cost-effectiveness analysis and formulary decision making in England: findings from research
Iestyn P Williams, Stirling Bryan
Health Economics
|
March 5, 2014
Breaking the addiction to technology adoption
Stirling Bryan, Craig Mitton, Cam Donaldson
BMC Research Notes
|
June 29, 2012
Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients
Billingsley Kaambwa, Stirling Bryan, Lucinda Billingham
Journal of Health Services Research & Policy
|
September 15, 2012
'Innovation' in health care coverage decisions: all talk and no substance?
Stirling Bryan, Helen Lee, Craig Mitton
Healthcarepapers
|
May 1, 2012
Let's all go to the PROM: the case for routine patient-reported outcome measurement in Canadian healthcare
Kimberlyn McGrail, Stirling Bryan, Jennifer Davis
Health Economics
|
August 31, 2012
Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials
Mohsen Sadatsafavi, Carlo Marra, Stirling Bryan
Page
of 20
Search research articles
Search
Showing results (11-20 of 192) with videos related to
Sort By:
Page
of 20
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 22, 2005
Measuring health-related utility: why the disparity between EQ-5D and SF-6D?
Stirling Bryan, Louise Longworth
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Discrete choice experiments in health economics. For better or for worse?
Stirling Bryan, Paul Dolan
International Journal of Health Policy and Management
|
March 12, 2018
Health Services Research Spending and Healthcare System Impact Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal"
Morris L Barer, Stirling Bryan
British Journal of Sports Medicine
|
March 26, 2015
Patient Reported Outcome Measures (PROMs) have arrived in sports and exercise medicine: Why do they matter?
Jennifer C Davis, Stirling Bryan
Social Science & Medicine (1982)
|
August 19, 2007
Cost-effectiveness analysis and formulary decision making in England: findings from research
Iestyn P Williams, Stirling Bryan
Health Economics
|
March 5, 2014
Breaking the addiction to technology adoption
Stirling Bryan, Craig Mitton, Cam Donaldson
BMC Research Notes
|
June 29, 2012
Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients
Billingsley Kaambwa, Stirling Bryan, Lucinda Billingham
Journal of Health Services Research & Policy
|
September 15, 2012
'Innovation' in health care coverage decisions: all talk and no substance?
Stirling Bryan, Helen Lee, Craig Mitton
Healthcarepapers
|
May 1, 2012
Let's all go to the PROM: the case for routine patient-reported outcome measurement in Canadian healthcare
Kimberlyn McGrail, Stirling Bryan, Jennifer Davis
Health Economics
|
August 31, 2012
Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials
Mohsen Sadatsafavi, Carlo Marra, Stirling Bryan
Page
of 20